Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): Safety analyses of a randomized clinical trial.

Aerobic treadmill training safety serious adverse events stroke rehabilitation subacute stroke

Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 17 3 2021
medline: 23 3 2022
entrez: 16 3 2021
Statut: ppublish

Résumé

To report the six-month safety analyses among patients enrolled in the "Physical Fitness Training in Subacute Stroke-PHYS-STROKE" trial and identify underlying risk factors associated with serious adverse events. We performed a pre-specified safety analysis of a multicenter, randomized controlled, endpoint-blinded trial comprising 200 patients with moderate to severe subacute stroke (days 5-45 after stroke) that were randomly assigned (1:1) to receive either aerobic, bodyweight supported, treadmill-based training (n = 105), or relaxation sessions (n = 95, control group). Each intervention session lasted for 25 min, five times weekly for four weeks, in addition to standard rehabilitation therapy. Serious adverse events defined as cerebro- and cardiovascular events, readmission to hospital, and death were assessed during six months of follow-up. Incident rate ratios (IRR) were calculated, and Poisson regression analyses were conducted to identify risk factors for serious adverse events and to test the association with aerobic training. Six months after stroke, 50 serious adverse events occurred in the trial with a higher incidence rate (per 100 patient-months) in the training group compared to the relaxation group (6.31 vs. 3.22; IRR 1.70, 95% CI 0.96 to 3.12). The association of aerobic training with serious adverse events incidence rates were modified by diabetes mellitus (IRR for interaction: 7.10, 95% CI 1.56 to 51.24) and by atrial fibrillation (IRR for interaction: 4.37, 95% CI 0.97 to 31.81). Safety analysis of the PHYS-STROKE trial found a higher rate of serious adverse events in patients randomized to aerobic training compared to control within six months after stroke. Exploratory analyses found an association between serious adverse events occurrence in the aerobic training group with pre-existing diabetes mellitus and atrial fibrillation which should be further investigated in future trials. The raw data and analyses scripts are provided by the authors on a secure online repository for reproduction of reported findings.

Sections du résumé

BACKGROUND AND AIM
To report the six-month safety analyses among patients enrolled in the "Physical Fitness Training in Subacute Stroke-PHYS-STROKE" trial and identify underlying risk factors associated with serious adverse events.
METHODS
We performed a pre-specified safety analysis of a multicenter, randomized controlled, endpoint-blinded trial comprising 200 patients with moderate to severe subacute stroke (days 5-45 after stroke) that were randomly assigned (1:1) to receive either aerobic, bodyweight supported, treadmill-based training (n = 105), or relaxation sessions (n = 95, control group). Each intervention session lasted for 25 min, five times weekly for four weeks, in addition to standard rehabilitation therapy. Serious adverse events defined as cerebro- and cardiovascular events, readmission to hospital, and death were assessed during six months of follow-up. Incident rate ratios (IRR) were calculated, and Poisson regression analyses were conducted to identify risk factors for serious adverse events and to test the association with aerobic training.
RESULTS
Six months after stroke, 50 serious adverse events occurred in the trial with a higher incidence rate (per 100 patient-months) in the training group compared to the relaxation group (6.31 vs. 3.22; IRR 1.70, 95% CI 0.96 to 3.12). The association of aerobic training with serious adverse events incidence rates were modified by diabetes mellitus (IRR for interaction: 7.10, 95% CI 1.56 to 51.24) and by atrial fibrillation (IRR for interaction: 4.37, 95% CI 0.97 to 31.81).
CONCLUSIONS
Safety analysis of the PHYS-STROKE trial found a higher rate of serious adverse events in patients randomized to aerobic training compared to control within six months after stroke. Exploratory analyses found an association between serious adverse events occurrence in the aerobic training group with pre-existing diabetes mellitus and atrial fibrillation which should be further investigated in future trials.
DATA ACCESS STATEMENT
The raw data and analyses scripts are provided by the authors on a secure online repository for reproduction of reported findings.

Identifiants

pubmed: 33724085
doi: 10.1177/17474930211006286
pmc: PMC8739607
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-100

Références

Lancet. 2011 May 14;377(9778):1693-702
pubmed: 21571152
Cochrane Database Syst Rev. 2020 Mar 20;3:CD003316
pubmed: 32196635
BMC Neurol. 2013 Dec 11;13:197
pubmed: 24330706
J Cardiopulm Rehabil Prev. 2018 May;38(3):139-146
pubmed: 29697494
Trials. 2014 Feb 03;15:45
pubmed: 24491065
J Diabetes Investig. 2019 May;10(3):780-792
pubmed: 30220102
Int J Stroke. 2016 Jun;11(4):459-84
pubmed: 27079654
Phys Ther. 2020 Jan 23;100(1):149-156
pubmed: 31596465
Front Neurol. 2019 Nov 15;10:1187
pubmed: 31803129
Stroke. 2018 Dec;49(12):2830-2836
pubmed: 30571393
Stroke. 2014 Aug;45(8):2532-53
pubmed: 24846875
BMJ. 2019 Sep 18;366:l5101
pubmed: 31533934
Can J Cardiol. 2013 Apr;29(4):483-91
pubmed: 23200094
Phys Ther. 2014 Dec;94(12):1796-806
pubmed: 25082924
J Cardiopulm Rehabil Prev. 2019 Mar;39(2):65-72
pubmed: 30801433

Auteurs

Torsten Rackoll (T)

Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.
NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health QUEST Center for Transforming Biomedical Research Charité - Universitätsmedizin Berlin, Berlin, Germany.

Alexander H Nave (AH)

Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Institute of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Martin Ebinger (M)

Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Neurology, Medical Park Berlin Humboldtmühle, Berlin, Germany.

Matthias Endres (M)

Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Institute of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE), Partner Site Berlin, Berlin, Germany.

Ulrike Grittner (U)

Berlin Institute of Health (BIH), Berlin, Germany.
Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Agnes Flöel (A)

Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Neurology, University Medicine Greifswald, Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH